Hyperglycemia after pediatric cardiac surgery: Impact of age and residual lesions

Critical Care Medicine

Volumn 39, Issue 2, 2011, Pages 266-272

  Moga, Michael Alice ^a   Manlhiot, Cedric ^b   Marwali, Eva M ^a   McCrindle, Brian W ^b   Van Arsdell, Glen S ^c,d   Schwartz, Steven M ^a,b  

^a Division of Cardiac Critical Care Medicine   (United States)

^b Division of Cardiology   (United States)

^c Division of Cardiovascular Surgery   (United States)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

cardiovascular surgery; hyperglycemia; intensive care; pediatrics

Indexed keywords

GLUCOSE; INSULIN; METHYLPREDNISOLONE; PROSTAGLANDIN; STEROID;

ARTICLE; ARTIFICIAL VENTILATION; CARDIOPULMONARY BYPASS; CYANOSIS; DEATH; DISEASE SEVERITY; EXTRACORPOREAL OXYGENATION; FEMALE; GLUCOSE BLOOD LEVEL; GROUPS BY AGE; HEART ARREST; HEART INJURY; HEART SURGERY; HUMAN; HYPERGLYCEMIA; INCIDENCE; INFANT; INSULIN TREATMENT; INTENSIVE CARE; LACTIC ACIDOSIS; LIVER FAILURE; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; OUTCOME ASSESSMENT; PEDIATRIC SURGERY; PERIOPERATIVE PERIOD; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR;

EID: 79251564664     PISSN: 00903493     EISSN: 15300293     Source Type: Journal    
DOI: 10.1097/CCM.0b013e3181fee88e     Document Type: Article

References (26)

1. Krinsley JS: Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients. Mayo Clin Proc 2003; 78:1471-1478
2. Wintergerst KA, Buckingham B, Gandrud L, et al: Association of hypoglycemia, hyperglycemia, and glucose variability with morbidity and death in the pediatric intensive care unit. Pediatrics 2006; 118:173-179
3. Langouche L, Vanhorebeek I, Vlasselaers D, et al: Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest 2005; 115:2277-2286
4. Vanhorebeek I, De Vos R, Mesotten D, et al: Protection of hepatocyte mitochondrial ultrastructure and function by strict blood glucose control with insulin in critically ill patients. Lancet 2005; 365:53-59
5. Vanhorebeek I, Ellger B, De Vos R, et al: Tissue-specific glucose toxicity induces mitochondrial damage in a burn injury model of critical illness. Crit Care Med 2009; 37: 1355-1364
6. Vanhorebeek I, Langouche L, Van den Berghe G: Glycemic and nonglycemic effects of insulin: How do they contribute to a better outcome of critical illness? Curr Opin Crit Care 2005; 11:304-311
7. Van den Berghe G, Wilmer A, Hermans G, et al: Intensive insulin therapy in the medical ICU. N Engl J Med 2006; 354:449-461
8. van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345: 1359-1367
9. Brunkhorst FM, Engel C, Bloos F, et al: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358:125-139
10. Finfer S, Chittock DR, Su SY, et al: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009; 360: 1283-1297
11. Yung M, Wilkins B, Norton L, et al: Glucose control, organ failure, and mortality in pediatric intensive care. Pediatr Crit Care Med 2008; 9:147-152
12. Faustino EV, Apkon M: Persistent hyperglycemia in critically ill children. J Pediatr 2005; 146:30-34
13. Srinivasan V, Spinella PC, Drott HR, et al: Association of timing, duration, and intensity of hyperglycemia with intensive care unit mortality in critically ill children. Pediatr Crit Care Med 2004; 5:329-336
14. Loepke AW, Spaeth JP: Glucose and heart surgery: Neonates are not just small adults. Anesthesiology 2004; 100:1339-1341
15. Polito A, Thiagarajan RR, Laussen PC, et al: Association between intraoperative and early postoperative glucose levels and adverse outcomes after complex congenital heart surgery. Circulation 2008; 118:2235-2242
16. Preissig CM, Rigby MR, Maher KO: Glycemic control for postoperative pediatric cardiac patients. Pediatr Cardiol 2009; 30:1098-1104
17. Rossano JW, Taylor MD, Smith EO, et al: Glycemic profile in infants who have undergone the arterial switch operation: Hyperglycemia is not associated with adverse events. J Thorac Cardiovasc Surg 2008; 135: 739-745
18. Yates AR, Dyke PC 2nd, Taeed R, et al: Hyperglycemia is a marker for poor outcome in the postoperative pediatric cardiac patient. Pediatr Crit Care Med 2006; 7:351-355
19. de Ferranti S, Gauvreau K, Hickey PR, et al: Intraoperative hyperglycemia during infant cardiac surgery is not associated with adverse neurodevelopmental outcomes at 1, 4, and 8 years. Anesthesiology 2004; 100:1345-1352
20. Falcao G, Ulate K, Kouzekanani K, et al: Impact of postoperative hyperglycemia following surgical repair of congenital cardiac defects. Pediatr Cardiol 2008; 29:628-636
21. Vlasselaers D, Milants I, Desmet L, et al: Intensive insulin therapy for patients in paediatric intensive care: A prospective, randomised controlled study. Lancet 2009; 373: 547-556
22. Hume R, Burchell A, Williams FL, et al: Glucose homeostasis in the newborn. Early Hum Dev 2005; 81:95-101
23. Onay-Besikci A: Regulation of cardiac energy metabolism in newborn. Mol Cell Biochem 2006; 287:1-11
24. Branco RG, Tasker RC: Glycemic level in mechanically ventilated children with bronchiolitis. Pediatr Crit Care Med 2007; 8:546-550
25. Krinsley JS: Glycemic variability: A strong independent predictor of mortality in critically ill patients. Crit Care Med 2008; 36: 3008-3013
26. Macrae D, Pappachan J, Grieve R, et al: Control of hyperglycaemia in paediatric intensive care (CHiP): Study protocol. BMC Pediatr 2010; 10:5